As of close of business last night, Equillium Inc’s stock clocked out at $2.78, up 9.45% from its previous closing price of $2.54. In other words, the price has increased by $+0.2400 from its previous closing price. On the day, 589172 shares were traded.
Ratios:
To gain a deeper understanding of EQ’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.11 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.42. For the most recent quarter (mrq), Quick Ratio is recorded 1.91 and its Current Ratio is at 1.91. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
On September 15, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $14.
H.C. Wainwright reiterated its Buy rating for the stock on July 14, 2020, while the target price for the stock was revised from $14 to $24.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EQ now has a Market Capitalization of 88.15M and an Enterprise Value of 42.77M. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.29 while its Price-to-Book (P/B) ratio in mrq is 4.05. Its current Enterprise Value per Revenue stands at 1.00 whereas that against EBITDA is -6.32.
Stock Price History:
Over the past 52 weeks, EQ has reached a high of $3.09, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is 1.0874, while the 200-Day Moving Average is calculated to be 0.7908.
Shares Statistics:
It appears that EQ traded 331.93K shares on average per day over the past three months and 571k shares per day over the past ten days. A total of 34.41M shares are outstanding, with a floating share count of 17.10M. Insiders hold about 51.30% of the company’s shares, while institutions hold 7.53% stake in the company. Shares short for EQ as of Jan 31, 2024 were 519.68k with a Short Ratio of 1.57, compared to 492.03k on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.48% and a Short% of Float of 2.37%.
Earnings Estimates
As of right now, 0 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.02. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is -$0.66, with 1 analysts recommending between -$0.66 and -$0.66.
Revenue Estimates
In the current quarter, 1 analysts expect revenue to total $8M. It ranges from a high estimate of $8M to a low estimate of $8M. As of the current estimate, Equillium Inc’s year-ago sales were $2.91M, an estimated increase of 174.50% from the year-ago figure.
A total of 1 analysts have provided revenue estimates for EQ’s current fiscal year. The highest revenue estimate was $34M, while the lowest revenue estimate was $34M, resulting in an average revenue estimate of $34M. In the same quarter a year ago, actual revenue was $10.98M, up 209.70% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $24M in the next fiscal year. The high estimate is $24M and the low estimate is $24M. The average revenue growth estimate for next year is down -29.40% from the average revenue estimate for this year.
